Table 4. Post-Randomization Between-Group Differences Adjusted for Baseline Values.
Outcome | Baseline (T1) M (SD) |
Post-treatment (T2) M (SD) |
Standardized coefficient ß | 95% CI | p |
---|---|---|---|---|---|
Mindfulness (FMI) | 27.27 (5.75) | 31.79 (4.50) | 0.34 | [0.06 - 0.63] | .01 |
Depression symptoms (PHQ-8) | 18.68 (3.39) | 16.89 (3.88) | -0.10 | [-0.39 - 0.21] | .52 |
Anxiety symptoms (GAD-7) | 17.27 (4.42) | 15.53 (3.84) | -0.42 | [-0.72 - -0.11] | .01 |
Stress level (PSS-4) | 13.38 (2.44) | 11.79 (2.05) | -0.14 | [-0.46 - 0.17] | .37 |
Wellbeing (WHO-5) | 35.20 (17.09) | 44.42 (15.44) | 0.37 | [0.07 - 0.68] | .02 |
PSS (Presenteeism-Work Impairment score) | 13.38 (2.44) | 27.66 (1.47) | -0.01 | [-0.34 - 0.32] | .94 |
Note. M = mean; SD = Standard deviation; FMI = Freiburg Mindfulness Inventory; GAD-7 = Generalized Anxiety Disorder Questionnaire; PHQ-8 = Patient Health Questionnaire; PSS = Presenteeism Scale for Students; PSS-4 = Short Form Perceived Stress Scale; WHO-5 = World Health Organization Well-Being Index.